Performance Evaluation of MALDI-TOF MS MBT STAR-BL Versus In-House Carba NP Testing for the Rapid Detection of Carbapenemase Activity in Escherichia coli and Klebsiella pneumoniae Strains
- 1 September 2019
- journal article
- research article
- Published by SAGE Publications in Microbial Drug Resistance
- Vol. 25 (7) , 985-990
Abstract
There is an urgent need to be able to identify carbapenemase-producing Enterobacterales. In this study we aimed to compare the performance of the MALDI Biotyper Selective Testing of Antibiotic Resistance-βLactamase (MBT STAR-BL) test with the in-house Carba NP test in their ability to rapidly detect carbapenemase production in Escherichia coli and Klebsiella pneumoniae strains. MBT STAR-BL and Carba NP testing were performed in parallel. One hundred sixty-nine isolates in total were tested. K. pneumoniae ( n = 139) and E. coli ( n = 14) strains with previously characterized carbapenemase types, and non-carbapenemase-producing strains of K. pneumoniae ( n = 8) and E. coli ( n = 8), were included in the study. When the results of the ertapenem and meropenem hydrolysis assays were evaluated together, MBT STAR-BL correctly identified 151 out of 153 (99%) carbapenemase producers as positive, while giving false-negative results for OXA-48 and OXA-48+NDM-1 producers in two K. pneumoniae isolates. The specificity and sensitivity of MBT STAR-BL were 100% and 98.69%, respectively. For the Carba NP test we confirmed 100% specificity, but sensitivity was 96.7%, although increasing to 100% when using prolonged incubation timing (4 hours). False-negative results were associated with enzymes with low carbapenemase activity, particularly OXA producers, which are common in Enterobacterales.Keywords
This publication has 21 references indexed in Scilit:
- MALDI-TOF for the rapid detection of carbapenemase-producing Enterobacteriaceae: comparison of the commercialized MBT STAR®-Carba IVD Kit with two in-house MALDI-TOF techniques and the RAPIDEC® CARBA NPJournal of Antimicrobial Chemotherapy, 2018
- The global epidemiology of carbapenemase-producing EnterobacteriaceaeVirulence, 2016
- Improvement of the Xpert Carba-R Kit for the Detection of Carbapenemase-Producing EnterobacteriaceaeAntimicrobial Agents and Chemotherapy, 2016
- Evaluation of three commercial assays for rapid detection of genes encoding clinically relevant carbapenemases in cultured bacteriaJournal of Antimicrobial Chemotherapy, 2015
- Detection of carbapenemases in Enterobacteriaceae: a challenge for diagnostic microbiological laboratoriesClinical Microbiology and Infection, 2014
- Temocillin and piperacillin/tazobactam resistance by disc diffusion as antimicrobial surrogate markers for the detection of carbapenemase-producing Enterobacteriaceae in geographical areas with a high prevalence of OXA-48 producersJournal of Antimicrobial Chemotherapy, 2013
- Carbapenem resistance in Enterobacteriaceae: here is the storm!Trends in Molecular Medicine, 2012
- Identification and screening of carbapenemase-producing EnterobacteriaceaeClinical Microbiology and Infection, 2012
- Carbapenemase Activity Detection by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass SpectrometryJournal of Clinical Microbiology, 2011
- Using Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry To Detect Carbapenem Resistance within 1 to 2.5 HoursJournal of Clinical Microbiology, 2011